New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

›ETF Issuers›Fidelity›FMED

FMED

Fidelity Disruptive Medicine ETF

Active ETF Equity Theme: Healthcare Technology & Innovation Theme: Life Sciences

Not rated

The FMED Exchange Traded Fund (ETF) is provided by Fidelity. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Fund key info

Issuer

Fidelity

ISIN

US3160921470

CUSIP

316092147

Fund AuM

€41M

Share class AuM

€41M

Share class info

USD Distributing

TER

0.5%

Fund details

NAV· 7/14/2026

$29.11

1D NAV change

-0.04%

Dividend policy

Distributing

No. of holdings

Inception date

6/12/2023

Jurisdiction

United States

Distribution

United States

Legal structure

Open-end Investment Company

Base currency

USD

Tax optimisation

PEA· France

UK Reporting Status· UK

Classification

Management strategy

Active ETF

Industry category

Asset class

Equity

Sector

Factors

Investment strategy

The fund seeks long-term growth of capital. Normally investing at least 80% of assets in securities of disruptive medicine companies.

Trading and listing info

$29.11

1D price range

N/A

52W price range

$22.99$30.15

Exchange

Legal documents

Annual report

Factsheet

KIID

Prospectus

Issuer

View all funds

Name

Fidelity

Number of funds

211

Total AuM

€236.79B

Issuer top 5 funds by AuM

FBND

Fidelity Total Bond ETF

-0.20%

FTEC

Fidelity MSCI Information Technology Index ETF

-0.70%

FBTC

Fidelity Wise Origin Bitcoin Fund

+1.44%

ONEQ

Fidelity NASDAQ Composite Index ETF

+1.12%

FENI

Fidelity Enhanced International ETF

-0.15%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Don’t Miss a Move in the ETF Market

Fidelity Disruptive Medicine ETF

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US